Rehabilitation for People with Respiratory Disease and Frailty: An Official American Thoracic Society Workshop Report.

"Author Disclosures: M.M. received research support from the National Institute for Health and Care Research (NIHR) Applied Research Collaboration South London (NIHR ARC South London) at King’s College Hospital NHS Foundation Trust. L.J.B. received research support from NIHR, Economic and Social Research Council. J.A.A. received research support from National Health and Medical Research Council Australia, Medical Research Futures Fund. S.P.B. served on an advisory committee for Boehringer Ingelheim, GlaxoSmithKline, Sanofi/Regeneron, Sunovion; served as a consultant for Boehringer Ingelheim, Sanofi/Regeneron; served as a speaker for Boehringer Ingelheim, IntegrityCE; received research support from NIH, Nuvaira, Sanofi/Regeneron. N.E.B. received research support from NIH. R.A.E. served as a consultant for AstraZeneca, British Medical Journal; served as a speaker for Boehringer Ingelheim, Chiesi, GlaxoSmithKline. L.E.F. received research support from NIH/NIA. O.F.F. received research support from Fogarty International Center and NIMH/NIH. F.M.F. served on an advisory committee for Chiesi, Novartis; served as a consultant for GlaxoSmithKline, Merck Sharp and Dohme; served as a speaker for AstraZeneca, Boehringer Ingelheim, Chiesi, Novartis; received research support from AstraZeneca. C.G. served as a speaker for Boehringer Ingelheim. S.L.H. received research support from NIHR. A.S.I. served as a consultant for AstraZeneca; served as a speaker for Ascension; received research support from NIH, National Institute on Aging. L.L. served as a consultant for AstraZeneca; served as a speaker for Chiesi, ISPA vzw; received research support from Funds for Scientific Research Flanders. A.L.L. received research support from NHMRC, Australian Physiotherapy Association and Physiotherapy Research Foundation. W.D.C.M. received research support from NIHR. D.R. received research support from Sandra Faire and Ivan Fecan Professorship in Rehabilitation Medicine. J.P.S. served on an advisory committee for Altavant, Mallinckrodt, Onspira; served as a consultant for 4C Medical received research support from NIH. M.A.S. served on an advisory committee for GlaxoSmithKline; served as a consultant for AstraZeneca, Boehringer Ingelheim; received research support from AstraZeneca, Boehringer Ingelheim, Chiesi, Netherlands Lung Foundation, Stichting Astma Bestrijding, Teva. C.R.O. served as a speaker for Novartis Australia; received research support from Australian Physiotherapy Association Physiotherapy Research Foundation, European Respiratory Society, GlaxoSmithKline, Rebecca L Cooper Medical Research Foundation, Royal Australian College of General Practitioners. J.A.A., L.T.B., C.B., M.C., S.L., A.M., H.J.C.M. reported no commercial or relevant non-commercial interests from ineligible companies."

"This document was funded by the American Thoracic Society. Author Disclosures: M.M. received research support from the National Institute for Health and Care Research (NIHR) Applied Research Collaboration South London (NIHR ARC South London) at King’s College Hospital NHS Foundation Trust. L.J.B. received research support from NIHR, Economic and Social Research Council. J.A.A. received research support from National Health and Medical Research Council Australia, Medical Research Futures Fund. S.P.B. served on an advisory committee for Boehringer Ingelheim, GlaxoSmithKline, Sanofi/Regeneron, Sunovion; served as a consultant for Boehringer Ingelheim, Sanofi/Regeneron; served as a speaker for Boehringer Ingelheim, IntegrityCE; received research support from NIH, Nuvaira, Sanofi/Regeneron. N.E.B. received research support from NIH. R.A.E. served as a consultant for AstraZeneca, British Medical Journal; served as a speaker for Boehringer Ingelheim, Chiesi, GlaxoSmithKline. L.E.F. received research support from NIH/NIA. O.F.F. received research support from Fogarty International Center and NIMH/NIH. F.M.F. served on an advisory committee for Chiesi, Novartis; served as a consultant for GlaxoSmithKline, Merck Sharp and Dohme; served as a speaker for AstraZeneca, Boehringer Ingelheim, Chiesi, Novartis; received research support from AstraZeneca. C.G. served as a speaker for Boehringer Ingelheim. S.L.H. received research support from NIHR. A.S.I. served as a consultant for AstraZeneca; served as a speaker for Ascension; received research support from NIH, National Institute on Aging. L.L. served as a consultant for AstraZeneca; served as a speaker for Chiesi, ISPA vzw; received research support from Funds for Scientific Research Flanders. A.L.L. received research support from NHMRC, Australian Physiotherapy Association and Physiotherapy Research Foundation. W.D.C.M. received research support from NIHR. D.R. received research support from Sandra Faire and Ivan Fecan Professorship in Rehabilitation Medicine. J.P.S. served on an advisory committee for Altavant, Mallinckrodt, Onspira; served as a consultant for 4C Medical received research support from NIH. M.A.S. served on an advisory committee for GlaxoSmithKline; served as a consultant for AstraZeneca, Boehringer Ingelheim; received research support from AstraZeneca, Boehringer Ingelheim, Chiesi, Netherlands Lung Foundation, Stichting Astma Bestrijding, Teva. C.R.O. served as a speaker for Novartis Australia; received research support from Australian Physiotherapy Association Physiotherapy Research Foundation, European Respiratory Society, GlaxoSmithKline, Rebecca L Cooper Medical Research Foundation, Royal Australian College of General Practitioners. J.A.A., L.T.B., C.B., M.C., S.L., A.M., H.J.C.M. reported no commercial or relevant non-commercial interests from ineligible companies."